Clinical trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian…
NCT00003386 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00003386 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer |
| Official title | Treatment of Ovarian Carcinoma With DNP-Modified Autologous Tumor Vaccine |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | BCG vaccine, autologous tumor cell vaccine, carboplatin, cisplatin, cyclophosphamide, paclitaxel, dinitrophenyl, surgical procedure |
| Start date | Jul 1, 1999 |
| Primary completion | Apr 1, 2001 |
| First posted | Apr 23, 2004 |
| Last update posted | Apr 11, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: